Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Pharmacol ; 860: 172529, 2019 Oct 05.
Article in English | MEDLINE | ID: mdl-31299187

ABSTRACT

Parasympathetic regulation of urinary bladder contractions primarily involves acetylcholine release and activation of detrusor smooth muscle (DSM) muscarinic acetylcholine (mACh) receptors. Co-release of ATP and activation of DSM purinergic P2X1-receptors may participate as well in some species. Both types of neuromuscular transmission (NMT) are impaired in diabetes, however, which factors may contribute to such impairment remains poorly understood. Here by using rats with streptozotocin(STZ)-induced type I diabetes (8th week after induction) we show that contribution of atropine-sensitive m-cholinergic component to the contractions of urothelium-denuded DSM strips evoked by electric field stimulation (EFS) greatly increased when diabetic bladders presented overt signs of accompanying cystitis. Modeling of hemorrhagic cystitis alone in control rats by cyclophosphamide injection only modestly increased m-cholinergic component of EFS-contractions. However, exposure of DSM strips from control animals to acetylcholinesterase (AChE) inhibitor, neostigmine (1-10 µM) largely reproduced alterations in EFS contractions observed in diabetic DSM complicated by cystitis. Ellman's assay revealed statistically significant 31% decrease of AChE activities in diabetic vs. control DSM. Changes in purinergic contractility of diabetic DSM were consistent with altered P2X1-receptor desensitization and re-sensitization. They could be mimicked by pharmacological inhibition of ATP-degrading ecto-ATPases with ARL 67156 (50 µM), pointing to compromised extracellular ATP clearance as underlying reason. We conclude that decreased AChE activities associated with diabetes and likely cystitis provide complementary factor to the described in literature altered expression of mACh receptor subtypes linked to diabetes as well as to cystitis to produce dramatic modification of cholinergic NMT.


Subject(s)
Acetylcholine/metabolism , Cystitis/complications , Diabetes Mellitus, Type 1/enzymology , Diabetes Mellitus, Type 1/physiopathology , Muscle Contraction , Neurotransmitter Agents/metabolism , Urinary Bladder/physiopathology , Acetylcholinesterase/genetics , Acetylcholinesterase/metabolism , Adenosine Triphosphate/metabolism , Animals , Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 1/metabolism , Disease Models, Animal , Extracellular Space/metabolism , Gene Expression Regulation, Enzymologic , Male , Rats , Rats, Wistar
2.
Life Sci ; 193: 207-213, 2018 Jan 15.
Article in English | MEDLINE | ID: mdl-29100756

ABSTRACT

AIMS: More than half of diabetic patients experience voiding disorder termed diabetic urinary bladder dysfunction (DBD). Here we have investigated how the alterations in transient receptor potential vanilloid 1 (TRPV1) ion channel expressed in bladder-innervating afferents may contribute to DBD pathogenesis. MAIN METHODS: The rat model of streptozotocin (STZ)-induced diabetes was used. The functional profile of TRPV1 in retrogradely labeled afferent, bladder-innervating dorsal root ganglia (DRG) neurons was examined using patch clamp. The level of TRPV1 transcripts in DRG was assessed with qRT-PCR. TRPV1-dependent component of detrusor smooth muscle (DSM) contractions was studied with muscle strip tensiometry. KEY FINDINGS: TRPV1-mediated current (ITRPV1) was increased in diabetic animals vs. controls by 42%. The expression of Trpv1 gene was found to be 63% higher in STZ-treated rats compared to controls, consistent with the respective electrophysiological data. Surprisingly, capsaicin-induced contractions of DSM were found to be 3-to-10-fold weaker in diabetic group depending on concentration of the agonist (100nM to 10µM). SIGNIFICANCE: Our findings suggest the dual role of TRPV1 in DBD. On the one hand, the increase of its functional expression may enhance micturition reflex arc functioning. On the other hand, at the local level, the decrease of TRPV1-dependent contractions may contribute to organ decompensation.


Subject(s)
TRPV Cation Channels/metabolism , Urinary Bladder/physiopathology , Animals , Capsaicin/pharmacology , Diabetes Mellitus, Experimental/metabolism , Disease Models, Animal , Ganglia, Spinal/drug effects , Male , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Neurons/drug effects , Patch-Clamp Techniques/methods , Rats , Rats, Wistar , Reflex/drug effects , Streptozocin/metabolism , TRPV Cation Channels/genetics , Urinary Bladder/metabolism
3.
J Smooth Muscle Res ; 52: 1-17, 2016.
Article in English | MEDLINE | ID: mdl-26935999

ABSTRACT

TRPA1 is a Ca(2+)-permeable cation channel that is activated by painful low temperatures (<17°C), irritating chemicals, reactive metabolites and mediators of inflammation. In the bladder TRPA1 is predominantly expressed in sensory afferent nerve endings, where it mediates sensory transduction. The contractile effect of its activation on detrusor smooth muscle (DSM) is explained by the release from sensory afferents of inflammatory factors - tachykinins and prostaglandins, which cause smooth muscle cell contraction. Diabetes is a systemic disease, with common complications being diabetic cystopathies and urinary incontinence. However, data on how diabetes affects bladder contractility associated with TRPA1 activation are not available. In this study, by using a rat model with streptozotocin-induced type I diabetes, contractility measurements of DSM strips in response to TRPA1-activating and modulating pharmacological agents and assessment of TRPA1 mRNA expression in bladder-innervating dorsal root ganglia, we have shown that diabetes enhances the TRPA1-dependent mechanism involved in bladder DSM contractility. This is not due to changes in TRPA1 expression, but mainly due to the general inflammatory reaction caused by diabetes. The latter leads to an increase in cyclooxygenase-2-dependent prostaglandin synthesis through the mechanisms associated with substance P activity. This results in the enhanced functional coupling between the tachykinin and prostanoid systems, and the concomitant increase of their impact on DSM contractility in response to TRPA1 activation.


Subject(s)
Diabetes Mellitus, Experimental/physiopathology , Muscle Contraction/genetics , Muscle Contraction/physiology , Muscle, Smooth/physiopathology , TRPC Cation Channels/physiology , Urinary Bladder/physiopathology , Animals , Cyclooxygenase 2/physiology , Male , Prostaglandins/biosynthesis , Rats, Wistar , Streptozocin , Substance P/metabolism , TRPA1 Cation Channel , TRPV Cation Channels/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...